154 related articles for article (PubMed ID: 35568304)
21. High-Grade Dysplasia in Resected Main-Duct Intraductal Papillary Mucinous Neoplasm (MD-IPMN) is Associated with an Increased Risk of Subsequent Pancreatic Cancer.
Majumder S; Philip NA; Singh Nagpal SJ; Takahashi N; Mara KC; Kendrick ML; Smyrk TC; Zhang L; Levy MJ; Gleeson FC; Petersen BT; Pearson RK; Topazian MD; Vege SS; Chari ST
Am J Gastroenterol; 2019 Mar; 114(3):524-529. PubMed ID: 30413822
[TBL] [Abstract][Full Text] [Related]
22. Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms.
Capurso G; Crippa S; Vanella G; Traini M; Zerboni G; Zaccari P; Belfiori G; Gentiluomo M; Pessarelli T; Petrone MC; Campa D; Falconi M; Arcidiacono PG
JAMA Netw Open; 2020 Nov; 3(11):e2022933. PubMed ID: 33252689
[TBL] [Abstract][Full Text] [Related]
23. Systematic review and meta-analysis of observational studies on BD-IPMNS progression to malignancy.
Balduzzi A; Marchegiani G; Pollini T; Biancotto M; Caravati A; Stigliani E; Burelli A; Bassi C; Salvia R
Pancreatology; 2021 May; ():. PubMed ID: 33994068
[TBL] [Abstract][Full Text] [Related]
24. Progression vs Cyst Stability of Branch-Duct Intraductal Papillary Mucinous Neoplasms After Observation and Surgery.
Marchegiani G; Pollini T; Andrianello S; Tomasoni G; Biancotto M; Javed AA; Kinny-Köster B; Amini N; Han Y; Kim H; Kwon W; Kim M; Perri G; He J; Bassi C; Goh BK; Katz MH; Jang JY; Wolfgang C; Salvia R
JAMA Surg; 2021 Jul; 156(7):654-661. PubMed ID: 34009303
[TBL] [Abstract][Full Text] [Related]
25. Incidence and Prevalence of Intraductal Papillary Mucinous Neoplasms in Individuals With BRCA1 and BRCA2 Pathogenic Variant.
Shah I; Silva-Santisteban A; Germansky KA; Wadhwa V; Tung N; Huang DC; Kandasamy C; Mlabasati J; Bilal M; Sawhney MS
J Clin Gastroenterol; 2023 Mar; 57(3):317-323. PubMed ID: 35220378
[TBL] [Abstract][Full Text] [Related]
26. The safety and benefit of pancreatic juice cytology under ERCP in IPMN patients.
Yoshioka T; Shigekawa M; Yamai T; Suda T; Kegasawa T; Iwahashi K; Ikezawa K; Sakamori R; Yakushijin T; Hiramatsu N; Tatsumi T; Takehara T
Pancreatology; 2016; 16(6):1020-1027. PubMed ID: 27567445
[TBL] [Abstract][Full Text] [Related]
27. Progression of Pancreatic Branch Duct Intraductal Papillary Mucinous Neoplasm Associates With Cyst Size.
Han Y; Lee H; Kang JS; Kim JR; Kim HS; Lee JM; Lee KB; Kwon W; Kim SW; Jang JY
Gastroenterology; 2018 Feb; 154(3):576-584. PubMed ID: 29074452
[TBL] [Abstract][Full Text] [Related]
28. [Branch duct intraductal papillary mucinous neoplasm - contra resection].
Brunner M; Weber GF; Kersting S; Grützmann R
Chirurg; 2017 Nov; 88(11):918-926. PubMed ID: 28871376
[TBL] [Abstract][Full Text] [Related]
29. Risk of pancreatic malignancy and mortality in branch-duct IPMNs undergoing surveillance: A systematic review and meta-analysis.
Crippa S; Capurso G; Cammà C; Fave GD; Castillo CF; Falconi M
Dig Liver Dis; 2016 May; 48(5):473-479. PubMed ID: 26965783
[TBL] [Abstract][Full Text] [Related]
30. Management and outcomes of intraductal papillary mucinous neoplasms.
Hipp J; Mohamed S; Pott J; Sick O; Makowiec F; Hopt UT; Fichtner-Feigl S; Wittel UA
BJS Open; 2019 Aug; 3(4):490-499. PubMed ID: 31388641
[TBL] [Abstract][Full Text] [Related]
31. International external validation of a stratification tool to identify branch-duct intraductal papillary mucinous neoplasms at lowest risk of progression.
Overbeek KA; van Leeuwen N; Tacelli M; Anwar MS; Yousaf MN; Chhoda A; Arcidiacono PG; Gonda TA; Wallace MB; Capurso G; Farrell JJ; Cahen DL; Bruno MJ
United European Gastroenterol J; 2022 Mar; 10(2):169-178. PubMed ID: 35199484
[TBL] [Abstract][Full Text] [Related]
32. Cyst features and risk of malignancy in intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis.
Anand N; Sampath K; Wu BU
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):913-21; quiz e59-60. PubMed ID: 23416279
[TBL] [Abstract][Full Text] [Related]
33. Assessment of Malignancy Potential in Intraductal Papillary Mucinous Neoplasms of the Pancreas on MDCT.
Chai L; Zhu N; Wang Q; Wang T; Chai W
Acad Radiol; 2021 May; 28(5):679-686. PubMed ID: 32591278
[TBL] [Abstract][Full Text] [Related]
34. "High-risk stigmata" of the 2012 international consensus guidelines correlate with the malignant grade of branch duct intraductal papillary mucinous neoplasms of the pancreas.
Aso T; Ohtsuka T; Matsunaga T; Kimura H; Watanabe Y; Tamura K; Ideno N; Osoegawa T; Takahata S; Shindo K; Ushijima Y; Aishima S; Oda Y; Ito T; Mizumoto K; Tanaka M
Pancreas; 2014 Nov; 43(8):1239-43. PubMed ID: 25036910
[TBL] [Abstract][Full Text] [Related]
35. Rapid Growth Rates of Suspected Pancreatic Cyst Branch Duct Intraductal Papillary Mucinous Neoplasms Predict Malignancy.
Kwong WT; Lawson RD; Hunt G; Fehmi SM; Proudfoot JA; Xu R; Giap A; Tang RS; Gonzalez I; Krinsky ML; Savides TJ
Dig Dis Sci; 2015 Sep; 60(9):2800-6. PubMed ID: 25924899
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic fat content may increase the risk of imaging progression in low-risk branch duct intraductal papillary mucinous neoplasm.
Kashiwagi K; Minami K; Seino T; Hirata K; Iwasaki E; Inoue N; Iwao Y; Kanai T
J Dig Dis; 2019 Oct; 20(10):557-562. PubMed ID: 31322828
[TBL] [Abstract][Full Text] [Related]
37. Indication for resection and possibility of observation for intraductal papillary mucinous neoplasm with high-risk stigmata.
Abe K; Kitago M; Masugi Y; Iwasaki E; Yagi H; Abe Y; Hasegawa Y; Fukuhara S; Hori S; Tanaka M; Nakano Y; Yokose T; Shimane G; Sakamoto M; Kitagawa Y
Pancreatology; 2021 Jun; 21(4):755-762. PubMed ID: 33632666
[TBL] [Abstract][Full Text] [Related]
38. Can contrast-enhanced harmonic endoscopic ultrasonography accurately diagnose main pancreatic duct involvement in intraductal papillary mucinous neoplasms?
Ohno E; Kawashima H; Ishikawa T; Iida T; Suzuki H; Uetsuki K; Yashika J; Yamada K; Yoshikawa M; Gibo N; Aoki T; Kataoka K; Mori H; Hirooka Y; Fujishiro M
Pancreatology; 2020 Jul; 20(5):887-894. PubMed ID: 32651080
[TBL] [Abstract][Full Text] [Related]
39. Number of Worrisome Features and Risk of Malignancy in Intraductal Papillary Mucinous Neoplasm.
Zelga P; Hernandez-Barco YG; Qadan M; Ferrone CR; Kambadakone A; Horick N; Jah A; Warshaw AL; Lillemoe KD; Balakrishnan A; Fernández-Del Castillo C
J Am Coll Surg; 2022 Jun; 234(6):1021-1030. PubMed ID: 35703792
[TBL] [Abstract][Full Text] [Related]
40. Demographic features and natural history of intermediate-risk multifocal versus unifocal intraductal papillary mucinous neoplasms.
Rosenblatt R; Dorfman V; Epelboym I; Poneros JM; Sethi A; Lightdale C; Woo Y; Gress FG; Allendorf JD; Schrope BA; Chabot JA; Gonda TA
Pancreas; 2015 Apr; 44(3):478-83. PubMed ID: 25411806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
